Technical Analysis for XLRN - Acceleron Pharma Inc.

Grade Last Price % Change Price Change
grade A 85.93 -0.74% -0.64
XLRN closed down 0.74 percent on Friday, February 28, 2020, on 1.63 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical XLRN trend table...

Date Alert Name Type % Chg
Wide Range Bar Range Expansion 0.00%
New Downtrend Bearish -0.74%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.74%
Wide Range Bar Range Expansion -0.74%
Multiple of Ten Bearish Other -0.74%
Strong but Oversold Other -0.74%
Outside Day Range Expansion -0.74%
Down 3 Days in a Row Weakness -0.74%
Down 4 Days in a Row Weakness -0.74%
Down 5 Days in a Row Weakness -0.74%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes (MDS), and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors. It has collaboration, license, and option agreement with Celgene Corporation. The company, formerly known as Phoenix Pharma, Inc., was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Biotechnology Cancer Life Sciences Rare Diseases Tumors Anemia Myelodysplastic Syndrome Celgene Myelodysplastic Syndromes Therapeutics For Cancer Ace 536

Is XLRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 95.95
52 Week Low 37.01
Average Volume 653,654
200-Day Moving Average 49.89
50-Day Moving Average 70.34
20-Day Moving Average 92.02
10-Day Moving Average 91.00
Average True Range 4.12
ADX 43.1
+DI 21.43
-DI 21.43
Chandelier Exit (Long, 3 ATRs ) 83.59
Chandelier Exit (Short, 3 ATRs ) 90.38
Upper Bollinger Band 98.19
Lower Bollinger Band 85.86
Percent B (%b) 0.01
BandWidth 13.40
MACD Line 4.97
MACD Signal Line 7.36
MACD Histogram -2.3862
Fundamentals Value
Market Cap 3.31 Billion
Num Shares 38.6 Million
EPS -2.49
Price-to-Earnings (P/E) Ratio -34.51
Price-to-Sales 108.28
Price-to-Book 7.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 98.89
Resistance 3 (R3) 99.28 95.34 96.73
Resistance 2 (R2) 95.34 92.04 95.15 96.01
Resistance 1 (R1) 90.64 90.00 92.99 90.25 95.29
Pivot Point 86.70 86.70 87.88 86.51 86.70
Support 1 (S1) 82.00 83.40 84.35 81.61 76.57
Support 2 (S2) 78.06 81.36 77.87 75.85
Support 3 (S3) 73.36 78.06 75.13
Support 4 (S4) 72.97